» Articles » PMID: 30448304

Association of Bone Mineral Density with Hemoglobin and Change in Hemoglobin Among Older Men and Women: The Cardiovascular Health Study

Overview
Journal Bone
Date 2018 Nov 19
PMID 30448304
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Osteoblasts and their precursors support hematopoiesis in the bone marrow. We hypothesized that declines in Hgb levels are associated with bone mineral density (BMD).

Methods: The Cardiovascular Health Study is a prospective longitudinal study that enrolled 5888 community-dwelling adults aged >65 years and measured hemoglobin twice, in 1989-90 and 1992-93, as well as BMD by dual-energy X-ray absorptiometry (DXA) in 1994-95. In a subset of 1513 men and women with a Hgb in 1992-93 and BMD, we used linear regression to estimate associations of Hgb (per standard deviation (SD)) with total hip (TH), lumbar spine (LS) and total body (TB) BMD, and used Poisson regression to estimate associations of anemia (in 1992-93; Hgb <13 g/dL in men; <12 g/dL in women) with "low BMD" defined as T-score less than -1 at the TH. In 1277 participants with Hgb measured on average 2.9 years apart and BMD, we used linear regression to estimate the associations of annualized change in Hgb with TH, LS and TB BMD. All models included age, sex, study-site, race, smoking, alcohol use, weight, height, steroid use, physical activity score, self-reported health, previous cardiovascular disease and prior anti-fracture medication use.

Results: No significant association was observed between Hgb, measured a mean 2.2 years prior to BMD, and BMD at the TH and LS in men (TH beta = -0.60 [x 10 g/cmper 1.1 g/dL Hgb], 95% CI: -1.88 to 0.68; LS beta = -1.69, 95% CI: -3.83 to 0.45) or women (TH beta = -0.49 [x 10 g/cmper 1.3 g/dL Hgb], 95% CI: -1.57 to 0.59; LS beta = -0.40, 95% CI: -2.57 to 1.76). Anemia was not observed to be significantly associated with low BMD in men (RR = 0.99, 95% CI: 0.72-1.40) nor women (RR = 0.98, 95% CI: 0.82-1.17). The mean change in Hgb was a loss of 0.06 g/dL/year (SD = 0.32). Change in Hgb was not observed to be significantly associated with BMD in men (TH beta = -0.55[x 10 g/cmper 1 g/dL annualized Hgb change], 95% CI: -4.28 to 3.19; LS beta = 0.63, 95% CI: -5.38 to 6.65) or women (TH beta = 0.92, 95% CI: -1.96 to 3.79; LS beta = -1.77, 95% CI: -7.52 to 3.98). No significant association was observed between anemia and low bone density by T-score in men and women.

Conclusions: These findings support neither the hypothesis that low Hgb prior to bone density or decreases in Hgb are associated with bone density in older community-dwelling adults nor the use of Hgb level as a case-finding tool to prompt BMD measurement.

Citing Articles

Effects of bone metabolism on hematopoiesis: A Mendelian randomization study.

Ho S, Hoi-Yee Li G, Leung A, Choon-Beng Tan K, Cheung C Osteoporos Sarcopenia. 2025; 10(4):151-156.

PMID: 39835327 PMC: 11742307. DOI: 10.1016/j.afos.2024.10.001.


Combining OSTA and BMR to predict osteoporosis in Chinese population.

Zhao J, Wang Y, Wang S, Guo Q, Wang W, Song J J Orthop Surg Res. 2024; 19(1):767.

PMID: 39558408 PMC: 11575123. DOI: 10.1186/s13018-024-05260-3.


Association of hemoglobin-to-red blood cell distribution width ratio and bone mineral density in older adults.

Xiao Y, Pan H, Huang R, Wu P, Peng C, Luo J BMC Musculoskelet Disord. 2024; 25(1):866.

PMID: 39472899 PMC: 11523879. DOI: 10.1186/s12891-024-07984-z.


Association between serum albumin with geriatric nutritional risk index and osteopenia in Chinese elderly men: a nested case-control study.

Li T, Zeng J, Miao X, Pan Z, Hu F, Cai X Asia Pac J Clin Nutr. 2024; 33(4):569-580.

PMID: 39209367 PMC: 11389811. DOI: 10.6133/apjcn.202412_33(4).0012.


Hemoglobin is associated with BMDs and risk of the 10-year probability of fractures in patients with type 2 diabetes mellitus.

Li R, Xu N, Guo Y, Wang Y, Liang Y, Zhou X Front Endocrinol (Lausanne). 2024; 15:1305713.

PMID: 38323109 PMC: 10846305. DOI: 10.3389/fendo.2024.1305713.


References
1.
Jovanovich A, Buzkova P, Chonchol M, Robbins J, Fink H, de Boer I . Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Clin Endocrinol Metab. 2013; 98(8):3323-31. PMC: 3733860. DOI: 10.1210/jc.2013-1152. View

2.
Gurkan U, Akkus O . The mechanical environment of bone marrow: a review. Ann Biomed Eng. 2008; 36(12):1978-91. DOI: 10.1007/s10439-008-9577-x. View

3.
Fried L, Borhani N, Enright P, Furberg C, Gardin J, Kronmal R . The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991; 1(3):263-76. DOI: 10.1016/1047-2797(91)90005-w. View

4.
Paccou J, Hardouin P, Cotten A, Penel G, Cortet B . The Role of Bone Marrow Fat in Skeletal Health: Usefulness and Perspectives for Clinicians. J Clin Endocrinol Metab. 2015; 100(10):3613-21. DOI: 10.1210/jc.2015-2338. View

5.
Gurevitch O, Khitrin S, Valitov A, Slavin S . Osteoporosis of hematologic etiology. Exp Hematol. 2007; 35(1):128-36. DOI: 10.1016/j.exphem.2006.09.010. View